BioLineRx and JHL Biotech to Collaborate on Type 1 Diabetes Antibody Treatment

News   Jan 09, 2014

 
BioLineRx and JHL Biotech to Collaborate on Type 1 Diabetes Antibody Treatment
 
 
 

RELATED ARTICLES

‘Lipid Asymmetry’ Plays Key Role in Activating Immune Cells

News

Regulating the lipid and physical asymmetry of a cell’s membrane is critical to immune cell function, and researchers have now shown that by preventing loss of membrane asymmetry it’s possible to control the immune response.

READ MORE

Studying Ebola-Host Cell Interaction Helps Find Targets for Antiviral Drugs

News

In some ways, the Ebola virus operates like a vampire; only after it is politely invited in to a host cell does it take up the task of destroying everything in its path. In a new study researchers seek to elucidate quantitatively the biomechanical mechanism of Ebola-host cell interaction, providing potential new targets for antiviral drug development.

READ MORE

Psoriasis Drug Also Reduces Aortic Inflammation

News

An antibody used to treat the autoimmune skin disease psoriasis is also effective at reducing aortic inflammation, a key marker of future risk of major cardiovascular events.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE